Salesforce.com Inc (CRM) Chairman of the Board & co-CEO Marc Benioff Sold $3.7 million of Shares (Guru Focus)
Chairman of the Board & co-CEO of Salesforce.com Inc., Marc Benioff, sold 20,000 shares of CRM on 01/30/2020 at an average price of $183.56 a share. The total sale was $3.7 million. Salesforce.com Inc is a software-as-a-service company that provides enterprise cloud computing solutions, offering social and mobile cloud apps and platform services, as well as professional services to facilitate the adoption of its solutions.
Friday 1/31 Insider Buying Report: APD, CLDB (Nasdaq.com)
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys. On Wednesday, Air Products & Chemicals’ Director, Edward L. Monser, made a $47,519 purchase of APD, buying 200 shares at a cost of $237.59 a piece. Monser was up about 1.3% on the purchase at the high point of today’s trading session, with APD trading as high as $240.65 in trading on Friday. Air Products & Chemicals is trading down about 1.2% on the day Friday. This buy marks the first one filed by Monser in the past year.
SEBI Disposes Of Insider Trading Case Against SpiceJet’s Former Independent Director (Bloomberg)
The Securities and Exchange Board of India on Friday disposed of an alleged insider trading case against former independent director of SpiceJet Ltd., KR Sasiprabhu, saying the charges could not be established against him. It had been alleged that Sasiprabhu had traded in the scrip of SpiceJet while in possession of unpublished price sensitive information pertaining to the company’s quarterly financial results. Sasiprabhu, who was appointed as an independent director of SpiceJet on Dec. 1, 2015, had resigned from the position in May, 2018, SEBI noted.
The President & CEO of Cidara Therapeutics is Exercising Options (Analyst Ratings)
Yesterday it was reported that the President & CEO of Cidara Therapeutics (CDTX), Jeffrey Stein, exercised options to buy 32,283 CDTX shares at $2.51 a share, for a total transaction value of $81.03K. The options were close to expired and Jeffrey Stein retained stocks. This recent transaction increases Jeffrey Stein’s holding in the company by 13.38% to a total of $1.94 million. Following Jeffrey Stein’s last CDTX Buy transaction on September 26, 2019, the stock climbed by 1.6%.
WeissLaw LLP: Sealed Air Corporation is the Subject of a Legal Investigation (PRNewswire.com)
NEW YORK, Jan. 30, 2020 /PRNewswire/ — WeissLaw LLP, a national class action and shareholders’ rights law firm with offices in New York, California and Georgia, announces an investigation of Sealed Air Corporation (NYSE: SEE) (“SEE,” or the “Company”). The investigation focuses on possible breaches of fiduciary duty and violations of federal securities laws by SEE’s Board of Directors for the alleged dissemination of materially false and misleading information in connection with the Company’s operations. Specifically, the Company is alleged to have improperly deducted $1.49 billion in asbestos claims relating to its purchase of Cryovac, and to have used a conflicted process to hire its independent auditor. As a result of an internal investigation by the Company’s Audit Committee, Senior Vice President and Chief Financial Officer William G. Stiehl, was fired for cause. Additionally, Stiehl and former director Lawrence R. Codey are alleged to have engaged in insider trading.
